News
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention as a tool ...
Lenacapavir, trialed in Uganda, offers 100% protection but will it reach those who need it most? Kampala, Uganda | RONALD ...
A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...
Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.
21h
The Print on MSNUNAIDS 2025 report warns of funding gaps in fight against HIV as India battles stigma, discriminationGlobal AIDS Update shows that 30% of surveyed Indians aged 15-49 reported facing stigma. Domestic violence, little autonomy ...
Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...
Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...
President Trump signed the budget bill, but the White House now demands Congress rescind more than $9 billion — including $400 million that funds America’s international ...
Every 10 minutes, an adolescent girl or young woman is infected with HIV in South Africa. But a long-acting injection could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results